News

AccentHealth enters into strategic relationship with American Cancer Society

BY Michael Johnsen

 

NEW YORK – AccentHealth on Thursday announced it has entered into a strategic relationship with the American Cancer Society. The announcement follows the recent launch of the AccentHealth Oncology Network, which features CNN-produced television programming for cancer patients in the waiting room, as well as printed "health panels" with oncology-specific educational information.
 
The companies plan to jointly develop oncology-specific content that will be integrated into the AccentHealth Oncology Network patient education products.
 
"AccentHealth recognizes that there is an increasing need for patient education around disease management and supportive care for cancer patients," said John Curbishley, EVP, business and product development for AccentHealth. "The growing financial and time pressures on oncologists make it more challenging for them to deliver critical information to their patients during diagnosis and treatment. Together, AccentHealth and the American Cancer Society can help by delivering trusted content that will educate and support cancer patients during this difficult time." 
 
 

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon’s entry would shake up the most?
News

FDA approves diabetes drug Afrezza

BY David Salazar

WASHINGTON — Afrezza, an inhaled insulin powder meant to treat diabetes patients, was approved Friday by the Food and Drug Administration.

 

The powder — manufactured by MannKind Corp. — is an inhalable dose of insulin that can be taken before meals to control blood sugar for patients with Type 1 and Type 2 diabetes. The drug is not meant to replace long-acting insulin in patients with Type 1 diabetes.

 

Along with approval, the FDA is requiring more clinical trials to test whether Afrezza is safe and effective for pediatric patients. Additionally, the approval comes with a plan to let doctors and pharmacists know that the drug poses a risk of acute bronchospasm when used by patients with asthma or Chronic Obstructive Pulmonary Disease.

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon’s entry would shake up the most?
News

Otherhood: Rewriting the fairytale

BY DSN STAFF

Women today play a dynamic role in society, and brands and marketers — including those within the retail pharmacy space — are tirelessly working to earn her trust and loyalty, as she often makes most of the healthcare decisions for her family. While reaching “moms” is no doubt important, new research suggests that brands and marketers may be missing a tremendous opportunity among those women who are rewriting the fairy tale. 

Enter “Otherhood.”

“Otherhood” consists of women from many different backgrounds: she could be single and never married, living with a partner or a same-sex partner, married with no children, separated, divorced or widowed. No matter her circumstances, she accounts for 47% of women of childbearing age, and she has significant buying power.

Fascinated by the insights revealed in the book, “Otherhood,” by author Melanie Notkin, consumer PR and social media agency DeVries Global set out to partner with Notkin and take a closer look at these women through a recently released study called “Shades
of Otherhood.” 

The insights revealed in the study, conducted in late 2013 among 1,000 non-moms and 1,000 moms across the country, debunk the myths and stereotypes about this influential group of women and highlight opportunities to target their needs.

 

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon’s entry would shake up the most?